Circulase investigators Selected Research

Ecraprost

5/2007	Adjunctive parenteral therapy with lipo-ecraprost, a prostaglandin E1 analog, in patients with critical limb ischemia undergoing distal revascularization does not improve 6-month outcomes.
4/2006	Parenteral therapy with lipo-ecraprost, a lipid-based formulation of a PGE1 analog, does not alter six-month outcomes in patients with critical leg ischemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Circulase investigators Research Topics

Disease

1	Pain (Aches) 05/2007
1	Chronic Limb-Threatening Ischemia 05/2007
1	Ischemia 04/2006
1	Peripheral Arterial Disease 04/2006

Drug/Important Bio-Agent (IBA)

2	Alprostadil (Muse)FDA LinkGeneric 05/2007 - 04/2006
2	EcraprostIBA 05/2007 - 04/2006
1	LipidsIBA 04/2006
1	ProdrugsIBA 04/2006
1	ProstaglandinsIBA 04/2006
1	EicosanoidsIBA 04/2006

Therapy/Procedure

2	Therapeutics 05/2007 - 04/2006
1	Surgical Amputation (Amputations) 05/2007